Short Interest in MDB Capital Holdings, LLC (NASDAQ:MDBH) Grows By 463.4%

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the target of a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 6,192 shares, a growth of 463.4% from the February 26th total of 1,099 shares. Based on an average trading volume of 8,191 shares, the short-interest ratio is currently 0.8 days. Approximately 0.1% of the shares of the company are sold short. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 8,191 shares, the short-interest ratio is currently 0.8 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of MDB Capital in a research report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

MDB Capital Stock Performance

MDBH traded up $0.07 during trading on Tuesday, reaching $2.95. 5,299 shares of the company traded hands, compared to its average volume of 5,974. The company has a market cap of $29.91 million, a P/E ratio of 3.17 and a beta of 1.05. MDB Capital has a 12-month low of $2.75 and a 12-month high of $6.52. The firm has a fifty day simple moving average of $3.16 and a 200 day simple moving average of $3.42.

Institutional Trading of MDB Capital

Institutional investors and hedge funds have recently bought and sold shares of the stock. Raymond James Financial Inc. bought a new position in shares of MDB Capital in the 2nd quarter valued at about $27,000. DRW Securities LLC bought a new stake in MDB Capital during the fourth quarter worth approximately $40,000. Finally, Citadel Advisors LLC bought a new stake in MDB Capital during the third quarter worth approximately $43,000. 0.35% of the stock is currently owned by institutional investors.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.